Data from various retinal clinical trials suggest that there is a difference in efficacy in anti-VEGF therapies for patients ...

The treatment showed stability or improvement in the Diabetic Retinopathy Severity Scale (DRSS) and generally the drug was well tolerated.

In keeping with current guidelines, either empagliflozin or dapagliflozin can be used for preventing AKI and CKD in patients with type 2 diabetes. Empagliflozin and dapagliflozin are equally ...

*Syndromes include WNF, West Nile meningitis, West Nile encephalitis and WNP. ‡ Overall, WNND represents 1% of human WNV infections. § WNP may occur in the context of any other manifestation of ...

Diabetic macular edema remains an important cause of vision loss among patients with diabetes mellitus. Improved control of blood pressure and blood sugar, as well as photocoagulation, are ...